Hamid Yousaif Qureshi: Japanese Scientists Develop Artificial Blood
Hamid Yousaif Qureshi, Expert in Medication Management and Patient-Centric Care, shared a post on LinkedIn:
“Researchers at Nara Medical University in Japan have been developing an experimental artificial blood substitute known as hemoglobin vesicles (HbV).
These are microscopic particles designed to carry oxygen in a way similar to red blood cells.
Each vesicle contains purified hemoglobin enclosed inside a lipid layer that functions like a simplified cell membrane.
One of the key advantages is compatibility. Natural blood must be carefully matched between donor and patient due to surface markers.
These vesicles do not carry those markers, meaning they could potentially be used across different blood types without matching.
Another major benefit is storage.
Donated blood typically lasts around 42 days, while these artificial vesicles can remain stable for much longer under controlled conditions.
This could make them useful in emergencies, disaster response, and areas where blood supply is limited.
However, this technology is still under development.
Natural blood performs many roles beyond oxygen transport, including clotting, immune response, and nutrient delivery.
Current versions of artificial blood are mainly designed to support oxygen delivery in specific situations.
Further research and clinical studies are ongoing to determine safety, effectiveness, and how this technology could be used in real-world medical care.
Source: Nara Medical University – research on hemoglobin vesicles.
Disclaimer: This content is for informational purposes only.
Courtesy:
MedStories.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025